IL-33-Induced Transcriptional Activation of LPIN1 Accelerates Breast Tumorigenesis

Cancers

Hong-Seok Choi¹  Jin-Young Kim¹  Garam Kim¹  Sung-Chul Lim² 

[1] College of Pharmacy, Chosun University, Gwangju 61452, Korea;Department of Pathology, School of Medicine, Chosun University, Gwangju 61452, Korea;

关键词: IL-33;    LPIN1;    COT;    JNK1/2;    c-Jun;   

DOI  :  10.3390/cancers13092174

来源: DOAJ

【 摘 要 】

Phospholipids are crucial materials that are not only required for cell membrane construction but also play significant roles as signaling molecules. LPIN1 is an enzyme that displays phosphatidate phosphatase activity in the triglyceride and phospholipid synthesis pathway. Recent studies have shown that overexpression of LPIN1 is involved in breast tumorigenesis, but the underlying mechanism regulating LPIN1 expression has not been elucidated yet. In the present study, we showed that the IL-33-induced COT-JNK1/2 signaling pathway regulates LPIN1 mRNA and protein expression by recruiting c-Jun to the LPIN1 promoter in breast cancer cells. IL-33 dose-dependently and time-dependently increased LPIN1 mRNA and protein expression. Moreover, IL-33 promoted colony formation and mammary tumorigenesis via induction of LPIN1 expression, while inhibition of LPIN1 disturbed IL-33-induced cell proliferation and mammary tumorigenesis. IL-33-driven LPIN1 expression was mediated by the COT-JNK1/2 signaling pathway, and inhibition of COT or JNK1/2 reduced LPIN1 expression. COT-JNK1/2-mediated IL-33 signaling activated c-Jun and promoted its binding to the promoter region of LPIN1 to induce LPIN1 expression. These findings demonstrated the regulatory mechanism of LPIN1 transcription by the IL-33-induced COT/JNK1/2 pathway for the first time, providing a potential mechanism underlying the upregulation of LPIN1 in cancer.

【 授权许可】

Unknown